Phases of Treatment: A Practical Approach to Methadone Maintenance Treatment

References

• Abdul-Quader A. S., Friedman S. R., Des Jarlais D., Marmor M. M., Maslansky R., Bartelme M. S. Methadone maintenance and behavior by intravenous drug users that can transmit HIV. Contemp. Drug Probl. 1987; 14: 425–434
   Google Scholar
• Anglin M. D., Speckart G. R., Booth M. W. Consequences and costs of shutting off methadone. Addict. Behav. 1989; 14: 307–326
   PubMed Web of Science ®Google Scholar
• Ball J. C., Lange W. R., Myers C. P., Friedman S. R. Reducing risk of AIDS through methadone maintenance treatment. J. Health Soc. Behav. 1988; 29: 214–226
   PubMed Web of Science ®Google Scholar
• Ball J. C., Ross A. The Effectiveness of Methadone Maintenance Treatment. Springer-Verlag, New York 1991
   Google Scholar
• Barthwell A., Senay E., Marks R., White R. Patients successfully maintained with methadone escaped Human Immunodeficiency Virus infection. Arch. Gen. Psychiatry 1989; 46: 957–958
   PubMed Web of Science ®Google Scholar
• Blaine J. D., Thomas D. B. Levo-alpha-acetylmethadol (LAAM): Clinical utility and pharmaceutical development. Substance Abuse: Clinical Problems and Perspectives, J. H. Lowinson, P. Ruiz. Williams and Wilkins, Baltimore, Maryland 1981; 360–388
   Google Scholar
• Caplehorn J. R. M., Bell J. Methadone dosage and retention of patients in maintenance treatment. Med. J. Aust. 1991; 151: 195–199
   Google Scholar
• Caplehorn J. R. M., McNeil D. R., Kleinbaum D. G. Clinic policy and retention in methadone maintenance. Int. J. Addict. 1993; 28(1)73–89
   PubMed Web of Science ®Google Scholar
• CENTERS FOR DISEASE CONTROL. HIV/AIDS Surveillance Report. October, 1992
   Google Scholar
• Chaisson R. E., Bacchetti P., Osmond D., Brodie B., Sande M., Moss A. R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989; 261: 561–565
   PubMed Web of Science ®Google Scholar
• Condelli W. S., Dunteman G. H. Exposure to methadone programs and heroin use. Am. J. Drug Alcohol Abuse 1993; 19: 65–78
   PubMed Web of Science ®Google Scholar
• Cooper J. R. Ineffective use of psychoactive drugs. Methadone treatment is no exception. JAMA 1992; 267: 281–282
   PubMed Web of Science ®Google Scholar
• Research on Treatment of Narcotic Addiction: State of the Art, J. R. Cooper, F. Altman, B. S. Brown, D. Czechowicz. National Institute on Drug Abuse, U.S. Department of Health and Human Services Publication, Rockville, Maryland 1983, [(ADM) 83–1281]
   Google Scholar
• Cushman P. Detoxification of rehabilitated methadone patients: Frequency and predictors of long-term success. Am. J. Drug Alcohol Abuse 1974; 1: 393–408
   PubMed Web of Science ®Google Scholar
• D'Aunno T. D., Vaughn T. E. Variations in methadone treatment practices. Results from a national study. JAMA 1992; 267: 253–258
   PubMed Web of Science ®Google Scholar
• De Leon G., Sacks S., Hilton R. Passages: A modified therapeutic community day treatment model for methadone clients. Innovative Approaches to the Treatment of Drug Abuse: Program Models and Strategies, J. A. Inciardi, F. M. Timms, B. Fletcher. Greenwood Press, Westport, Connecticut, in press
   Google Scholar
• Des Jarlais D. C., Friedman S. R., Strug D. AIDS and needle sharing within the IV drug use subculture. The Social Dimensions of AIDS: Methods and Theory, D. Feldman, T. Johnson. Pregor, New York 1986
   Google Scholar
• Dole V. P. Implications of methadone maintenance for theories of narcotic addiction. JAMA 1988; 260: 3025–3029
   PubMed Web of Science ®Google Scholar
• Dole V. P. Methadone treatment and the Acquired Immunodeficiency Syndrome epidemic. JAMA 1989; 262: 1681–1682
   PubMed Web of Science ®Google Scholar
• Dole V. P., Joseph H. Long-term outcome of patients treated with methadone maintenance. Ann. N. Y. Acad. Sci. 1978; 311: 181–189
   PubMedGoogle Scholar
• Dole V. P., Nyswander M. E., Des Jarlais D., Joseph H. Performance-based ratings of methadone maintenance programs. New Engl. J. Med. 1982; 306: 169–172
   PubMed Web of Science ®Google Scholar
• FEDERAL REGISTER., Department of Health and Human Services. Food and Drug Administration. 21 CFR Part 291. Methadone in maintenance treatment of narcotic addicts; Joint revision of conditions for use; Interim maintenance treatment. Human Immunodeficiency Virus disease counseling January 6, 1993; 58(3)495–499
   Google Scholar
• Gelb A. M., Mildvan D., Stenger R. J. The spectrum and causes of liver disease in narcotic addicts. Am J Gastroenterol. 1977; 67: 314–318
   PubMed Web of Science ®Google Scholar
• Gerstein D. R. The effectiveness of drug treatment. Addictive States, C. P. O'Brien, J. H. Jaffe. Raven Press, New York 1992
   Google Scholar
• Gold M. L., Sorenson J. L., McCanlies N., Trier M., Dlugosch G. Tapering from methadone maintenance: Attitudes of clients and staff. J. Substance Abuse Treatment 1988; 5: 37–44
   PubMed Web of Science ®Google Scholar
• Gorski T. T., Miller M. Staying Sober: A Guide to Relapse Prevention. Herald House, Independence, Missouri 1986
   Google Scholar
• Ho A., Dole V. P. Pain perception in drug-free and in methadone-maintained human ex-addicts. Proc. Soc. Exp. Biol. Med. 1979; 162: 392–395
   PubMed Web of Science ®Google Scholar
• Hoffman J. A., Caudill B. D., Landry M., Medlin J. Living in Balance: A Comprehensive Cocaine Abuse Treatment and Relapse Prevention Manual. Koba Associates, Washington, DC 1993
   Google Scholar
• Hubbard R. L., Marsden M. E., Cavanaugh E. R., Rachal J. V., Ginzburg H. M. Role of drug-abuse treatment in limiting the spread of AIDS. Rev. Infect. Dis. 1988; 10: 377–384
   PubMedGoogle Scholar
• Hubbard R. L., Marsden M. E., Rachal J. V., Harwood H. J., Cavanaugh E. R., Ginzburg H. M. Drug Abuse Treatment: A National Study of Effectiveness. The University of North Carolina Press, Chapel Hill, North Carolina 1989
   Google Scholar
• Jasinski D. R., Johnson R. E., Kocher T. R. Clonidine in morphine withdrawal: Differential effects on signs and symptoms. Arch. Gen. Psychiatry 1985; 42: 1063–1066
   PubMed Web of Science ®Google Scholar
• Kleber H. D., Topaxian M., Gaspari J., Riordan C. E., Kosten T. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. Am. J. Drug Alcohol Abuse 1987; 13: 1–17
   PubMed Web of Science ®Google Scholar
• Kleiman M. A., Caulkins J. P. Heroin policy for the next decade. Ann. Am. Acad. Polit. Soc. Sci. 1992; 521: 163–174
   Google Scholar
• Koob G. F., Bloom F. E. Cellular and molecular mechanisms of drug dependence. Science 1988; 242: 715–723
   PubMed Web of Science ®Google Scholar
• Kreek M. J. Factors modifying the pharmacological effectiveness of methadone. Research on the Treatment of Narcotic Addiction: State of the Art, J. R. Cooper, F. Altman, B. S. Brown. National Institute on Drug Abuse, Rockville, Maryland 1983; 95–107, [(ADM) 83–1281]
   Google Scholar
• Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors, G. A. Marlatt, J. R. Gordon. Guilford Press, New York 1985
   Google Scholar
• McGlothlin W. H., Anglin M. D. Shutting off methadone. Arch. Gen. Psychiatry 1981; 38: 885–892
   PubMed Web of Science ®Google Scholar
• McLellan A. T. Patient characteristics associated with outcome. Research on the Treatment of Narcotic Addiction: State of the Art, J. R. Cooper, F. Altman, B. S. Brown. National Institute on Drug Abuse, Rockville, Maryland 1983, [(ADM) 83–1281].
   Google Scholar
• McLellan A. T., Luborsky L., Woody G. E., O'Brien C. P., Druley K. A. Is treatment for substance abuse effective?. JAMA 1982; 247: 1423–1427
   PubMed Web of Science ®Google Scholar
• Metzger D. S., Woody G. E., McLellan A. T., O'Brien C. P., Druley P. Human Immunodeficiency Virus seroconversion among in- and out-of-treatment intravenous drug users: An 18-month prospective follow-up. J. Acquired Immune Deficiency Syndrome., in press
   Google Scholar
• Milby J. B., Gurwitch R. H., Hohmann A. A., Wiebe D. J., Ling W., McLellan A. T., Woody G. E. Assessing pathological detoxification fear among methadone maintenance patients. The DFSS. J. Clin. Psychol. 1987; 43: 528–538
   PubMed Web of Science ®Google Scholar
• Novick D. M., Joseph H. Medical maintenance: The treatment of chronic opiate dependence in general medical practice. J. Substance Abuse Treatment 1991; 8: 233–239
   PubMed Web of Science ®Google Scholar
• Novick D. M., Joseph H., Croxson T. S., Salsitz E. A., Wang G., Richman B. L. Absence of antibody to human deficiency in long-term, socially rehabilitated methadone maintenance patients. Arch. Intern. Med. 1990; 150: 97–99
   PubMed Web of Science ®Google Scholar
• Nyswander M. E., Dole V. P. The treatment of chronic pain. New Engl. J. Med. 1984; 310: 599
   Google Scholar
• Payte J. T., Khuri E. T. Principles of methadone dose determination. M. W. Parrino (Consensus Panel Chair), State Methadone Maintenance Treatment Guidelines (draft). Center for Substance Abuse Treatment, U.S. Department of Health and Human Services, Rockville, Maryland 1992; 101–124
   Google Scholar
• Phillips C., Fountain D., Hubbard R., Forsyth B., Dunteman G. Methadone Treatment Quality Assurance System (MTQAS) Feasibility Study: Results from Part One of the Field Test. Center for Social Research and Policy: Research Triangle Institute. 1992, Report to the National Institute on Drug Abuse (271-89-8532).
   Google Scholar
• Quinones M. A., Doyle K. M., Sheffet A., Louria D. B. Am. J. Public Health 1979; 13: 1164–1169
   Google Scholar
• Rosenbaum M. Staying off methadone maintenance. J. Psychoactive Drugs 1991; 23(3)251–260
   PubMed Web of Science ®Google Scholar
• Rosenbaum M., Irwin J., Murphy S. De facto de-stabilization as policy: The impact of short-term methadone maintenance. Contemp. Drug Probl. 1988; 491–517
   Google Scholar
• Selwyn P. A. Issues in the clinical management of intravenous drug users with HIV infection. AIDS 1989; 3(1)S201–S208
   Google Scholar
• Simpson D. D., Joe G. W., Lehman W. E. K., Sells B. Addiction careers: Etiology, treatment, and 12-year follow-up outcomes. J. Drug Issues 1986; 16: 107–121
   Web of Science ®Google Scholar
• Stimmel B. Intravenous drug use, methadone, and AIDS: Ask not for whom the bell tolls. J. Addict. Dis. 1993; 12(1)1–5
   Google Scholar
• Stitzer M. L., Iguchi M. Y., Felch L. J. Contingent take-home incentive: Effects on drug use of methadone maintenance patients. J. Consult. Clin. Psychol. 1992; 60(6)927–934
   PubMed Web of Science ®Google Scholar
• Strain E. C., Stitzer M. L., Bigelow G. E., Liebson I. Methadone Dosing Level: Effects on Treatment Outcome. Presented at the 53rd Annual Meeting Committee on Problems on Drug Dependence, Palm Beach. Florida 1991
   Google Scholar
• Street E. Interpersonal Process in Psychotherapy: A Guide for Clinical Training. Brooks/Cole Publishing Co, Pacific Grove, California 1992
   Google Scholar
• U.S. GENERAL ACCOUNTING OFFICE. Methadone Maintenance: Some Treatment Programs Are Not Effective; Greater Federal Oversight Needed. Washington, DC 1990, GAO/HRD-90–104
   Google Scholar
• Weinstein S. P., Gottheil E., Sterling R. C., Demaria P. A. Long-term methadone maintenance treatment: Some clinical examples. J. Substance Abuse Treatment 1993; 10: 277–281
   PubMed Web of Science ®Google Scholar
• Wermuth L., Brummett S., Sorensen J. L. Bridges and barriers to recovery: Clinical observations from an opiate recovery project. J. Substance Abuse Treatment 1987; 4: 189–196
   PubMed Web of Science ®Google Scholar
• Williams M. L. HIV seroprevalence among male IVDUs in Houston, Texas. Am. J. Public Health 1990; 80: 1507–1508
   PubMed Web of Science ®Google Scholar
• Yancovitz S. R., Des Jarlais D. C., Peyser N. P., Drew E., Friedmann P., Trigg H. L., Robinson J. W. A randomized trial of an interim methadone maintenance clinic. Am. J. Public Health 1991; 81(9)1185–1191
   PubMed Web of Science ®Google Scholar
• Zweben J. E., Payte J. T. Methadone maintenance in the treatment of opioid dependence—A current perspective. West. J. Med. 1990; 152: 588–599
   PubMedGoogle Scholar